Last updated: June 9, 2023
Sponsor: CurvaFix, Inc.
Overall Status: Active - Recruiting
Phase
N/A
Condition
Osteoporosis
Treatment
IM Implant
Clinical Study ID
NCT05606042
CLP-0002
ACTRN12622001125718
All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Subject, or their Authorized Representative, is willing and able to provide writteninformed consent, including authorization to release health information
- Subject has undergone pelvic or acetabular fixation using the IM Implant and the IMImplant was placed according to the manufacturer's labeling.
- Subject's pelvic or acetabular fixation with the IM Implant occurred within the last 30 calendar days.
Exclusion
Exclusion Criteria:
- Subject is unwilling or unable to provide written informed consent and/or does nothave an authorized representative who can provide consent on their behalf
- Subject presents with any condition or situation which, in the Investigator's opinion,puts the Subject at risk, could confound the study results, or may interfere with theSubject's participation in the study
Study Design
Total Participants: 200
Treatment Group(s): 1
Primary Treatment: IM Implant
Phase:
Study Start date:
November 24, 2021
Estimated Completion Date:
June 30, 2024
Study Description
Connect with a study center
Memorial Medical Center, Springfield
Springfield, Illinois 62781
United StatesActive - Recruiting
Missouri Orthopaedic Institute
Columbia, Missouri 65212
United StatesActive - Recruiting
Mount Carmel Research Institute
Columbus, Ohio 43219
United StatesActive - Recruiting
UT Health San Antonio
San Antonio, Texas 78229
United StatesActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.